Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China.
- Author:
Zheng XU
1
;
Li-Xin HUA
;
Li-Xin QIAN
;
Jie YANG
;
Xin-Ru WANG
;
Wei ZHANG
;
Hong-Fei WU
Author Information
- Publication Type:Journal Article
- MeSH: Adenocarcinoma; blood; epidemiology; genetics; Aged; China; epidemiology; DNA-Binding Proteins; blood; genetics; Genetic Predisposition to Disease; Genotype; Humans; Male; Odds Ratio; Polymorphism, Restriction Fragment Length; Prostatic Neoplasms; blood; epidemiology; genetics; Risk Factors; Seroepidemiologic Studies; X-ray Repair Cross Complementing Protein 1
- From: Asian Journal of Andrology 2007;9(3):331-338
- CountryChina
- Language:English
-
Abstract:
AIMTo investigate the association among XRCC1 polymorphisms, smoking, drinking and the risk of prostate cancer (PCa) in men from Han, Southern China.
METHODSIn a case-control study of 207 patients with PCa and 235 cancer-free controls, frequency-matched by age, we genotyped three XRCC1 polymorphisms (codons 194, 280 and 399) using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RELP) method.
RESULTSAmong the three polymorphisms, we found that the XRCC1 Arg399Gln variant allele was associated with increased PCa risk (adjusted odd ratio [OR]: 1.67, 95% confident interval [CI]: 1.11-2.51), but the XRCC1 Arg194Trp variant allele had a 38% reduction in risk of PCa (adjusted OR: 0.62, 95% CI: 0.41-0.93). However, there was no significant risk of PCa associated with Arg280His polymorphism. When we evaluated the three polymorphisms together, we found that the individuals with 194Arg/Arg wild-type genotype, Arg280His and Arg399Gln variant genotypes had a significantly higher risk of PCa (adjusted OR: 4.31; 95% CI: 1.24-14.99) than those with three wild-type genotypes. In addition, we found that Arg399Gln variant genotypes had a significant risk of PCa among heavy smokers (adjusted OR: 2.04; 95% CI: 1.03-4.05).
CONCLUSIONThese results suggest that polymorphisms of XRCC1 appear to influence the risk of PCa and may modify risks attributable to environmental exposure.
